Investment
Features
FeesSafety
Academy
More
Pluang+

Nordea boosts stake in Vertex Pharmaceuticals to $202.6M amid strong analyst buy ratings.

Market News
23 Mar 2026
Defense World
View Source
Neutral
pluang ai news

Nordea Investment Management increased its holdings in Vertex Pharmaceuticals by 23.8% in Q4, now owning shares worth $202.6 million. The company recently reported slightly missed earnings per share but showed revenue growth of 9.5% year-over-year. Analysts remain optimistic, with multiple firms raising price targets and maintaining buy or outperform ratings. Despite insider stock sales, institutional ownership remains high at over 90%, signaling strong confidence in Vertex's future prospects, especially given its leadership in cystic fibrosis treatments.

More News (VRTX)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App